Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results

Core Viewpoint - Cryo-Cell International, Inc. reported a 3% decrease in consolidated revenues for the third quarter of fiscal 2025 compared to the same period in fiscal 2024, indicating potential challenges in revenue generation [1]. Financial Results - Consolidated revenues for the third quarter of fiscal 2025 were $7.83 million, down from $8.07 million in the third quarter of fiscal 2024 [1]. - The company reported a net income figure, although the specific amount was not detailed in the provided text [1].